Screening of counterfeit corticosteroid in creams and ointments by NMR spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 70, Issue , 2012, Pages 245-250

  McEwen, Ian ^a   Elmsjö, Albert ^a   Lehnström, Angelica ^a   Hakkarainen, Birgit ^a   Johansson, Monika ^a,b  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

19F NMR; 1H NMR; Corticosteroids; Counterfeit drugs; Deuterium isotope effect; QNMR

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUMETASONE; HYDROCORTISONE; TRIAMCINOLONE;

ARTICLE; CREAM; EXTRACTION; HEALTH CARE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OINTMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADRENAL CORTEX HORMONES; CALIBRATION; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, LIQUID; COUNTERFEIT DRUGS; FRAUD; MAGNETIC RESONANCE SPECTROSCOPY; OINTMENTS; QUALITY CONTROL; REFERENCE STANDARDS; SKIN CREAM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84866257811     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.07.005     Document Type: Article

References (20)

1. NHS information. , 2011 (accessed 30.9.11). http://www.nhs.uk/Conditions/Corticosteroid-(drugs)/Pages/Sideeffects.aspx.
2. Gagliardi L., De Orsi D., Del Giudice M., Gatta F., Porrà R., Chimenti P., Tonelli D. Development of a tandem thin-layerchromatography-high-performance liquid chromatography method for the identification and determination of corticosteroids in cosmetic products. Anal. Chim. Acta 2002, 457:187-198.
3. Panusa A., Ottaviani M., Picardo M., Camera E., Gagliardi L., Chimenti P., Granese A., Tonelli D. Analysis of corticosteroids by high performance liquid chromatography-electrospray mass spectrometry. Analyst 2004, 129:719-723.
4. 19F NMR spectroscopic method for determination of insecticide diflubenzuron in different media. Food Chem. 2007, 105:1682-1687.
5. Smith E.W., Haigh J.M., Kanfer I. A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage forms. Int. J. Pharm. 1985, 27:185-192.
6. Hashem H., Jira Th. Determination of triamcinolone, prednisolone and dexamethasone in pharmaceutical tablet formulations using a solid phase extraction and a monolithic column. Chromatographia 2005, 61:133-136.
7. Garcia C.V., Breier A.R., Steppe M., Schapoval E.E.S., Oppe T.P. Determination of dexamethasone acetate in cream by HPLC. J. Pharm. Biomed. Anal. 2003, 31:597-600.
8. Reepmeyer J.C. Screening for corticosteroids in topical pharmaceuticals by HPLC with a scanning ultraviolet detector. J. Liq. Chromatogr. Relat. Technol. 2001, 24:693-709.
9. Holzgrabe U., Wawer I., Diehl B. NMR Spectroscopy in Drug Development and Analysis 1999, first ed., Wiley-VCH.
10. Malet-Martino M., Holzgrabe U. NMR techniques in biomedical and pharmaceutical analysis. J. Pharm. Biomed. Anal. 2011, 55:1-15.
11. Malz F., Jancke H. Validation of quantitative NMR. J. Pharm. Biomed. Anal. 2005, 38:813-823.
12. 19F NMR method validation and application to the quantitative analysis of a fluoro-polyphosphates mixture. J. Fluorine Chem. 2006, 127:809-815.
13. Martino R., Gilard V., Desmoulin F., Malet-Martino M. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. J. Pharm. Biomed. Anal. 2005, 38:871-891.
14. 1H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52:645-651.
15. 19F chemical shifts. Acta Chem. Scand. 1997, 51:881-888.
16. 1H isotope effects on carbon-13 chemical shifts in cycloalkanes. Downfield shifts over three and four bonds. J. Am. Chem. Soc. 1981, 103:1301-1303.
17. Williams D.H., Fleming I. Spectroscopy Methods in Organic Chemistry 1995, McGraw-Hill, London, p. 100. fifth ed.
18. Hansen P.E. Isotope effects on nuclear shielding. Annual Report on NMR Spectroscopy 1983, 106-186. Academic Press Inc., London. G.A. Webb, E.F. Mooney (Eds.).
19. Hansen P.E. Intrinsic deuterium isotope effect on NMR chemical shifts of hydrogen bonded systems. Nukleonika 2002, 47:37-43.
20. Paragraph 7.2 in ICH quality validation: , 2012 (accessed 04.01.12). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.